Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation

Table 1 Characteristics of 114 patients eligible for RFA but received TACE treatment

Characteristics	Median	Interquartile range
Age (yr)	63	55-71
Gender: male/female (n)	87/27	76/24
Child’s grading (n, %)
A	90	79
B	24	21
HBsAg status (n, %)
Positive	82	71
Negative	32	28
TNM stage (n, %)
Stage I	72	63
Stage II	39	34
Stage IIIA	1	1
Stage IIIC	2	2
Number of tumor nodules (n, %)	1	1-2
1	76	67
2	32	28
3	6	5
Size of largest tumor nodule (cm)	3	2.1-4.0
Tumor distribution (n, %)
Unilobar	88	77
Bilobar	26	23
Platelet count (×109/L)	98	72-128
Albumin (g/L)	37	33-41
Total bilirubin (μmol/L)	17	12-24
Prothrombin time (s)	13.2	11.9-14.6
INR	1.1	1.0-1.2
AFP (ng/mL)	80	15-373
Number of TACE procedures	5	3-8

TACE: transarterial chemoembolization; HBsAg: hepatitis B surface antigen; INR: international normalized ratio; values are median with their interquartile range, unless denoted otherwise.